None Rebalancing
EUR
Low Risk
1.2yr backtest

Performance Summary

Total Return+19.36%
Annualized Return+16.47%
Volatility+7.97%
Sharpe Ratio1.81
Max Drawdown+5.22%

Holdings

Asset Allocation

Asset Class

Equity 67.0%Money Market 33.0%
Holdings Details
This diversified equity and money market portfolio targets North America, Europe, and Emerging Markets for balanced global exposure.
AssetTypeAllocationTER
FI4000029327
OP-Amerikka Indeksi AFI4000029327
FUND
39.0%0.39%
XEON.XETRA
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1CLU0290358497
ETF
33.0%0.1%
FI4000029301
OP-Eurooppa Indeksi AFI4000029301
FUND
16.8%0.39%
IS3N.XETRA
iShares Core MSCI Emerging Markets IMI UCITSIE00BKM4GZ66
ETF
9.0%0.18%
DFEN.XETRA
VanEck Defense UCITS ETF AIE000YYE6WK5
ETF
1.3%0.55%
QUTM.XETRA
VanEck Quantum Computing UCITS ETF AIE0007Y8Y157
ETF
0.9%0.55%
Total100.0%0.28%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €11,935.6
Histogram of Monthly Returns
The portfolio had a positive return during 12 of the 15 months (80%)
Monthly Returns Heatmap
Best month: +6.1% • Worst month: -3.6% • Best year: 2025 (+9.8%) • Worst year: 2026 (+8.8%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+1.2%+0.9%-3.6%+6.1%+4.3%+0.9%-1.1%-----+8.8%
2025----+0.7%+0.9%+2.6%+0.1%+2.5%+2.9%-0.4%+0.2%+9.8%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +5.22% • The longest drawdown period lasted for 1 month and was between November 2025 and January 2026. It reached a trough of -2.8%.

Detailed Metrics

Returns
Total Return
+19.36%
Annualized Return
+16.47%
Avg Monthly Return
+1.21%
Risk
Volatility (Annual)
+7.97%
Max Drawdown
+5.22%
Positive Months
80%
Average Drawdown
-1.0%
Risk-Adjusted
Sharpe Ratio
1.81
Risk-free rate: 2.0%
Sortino Ratio
1.76
Downside risk adjusted
Return/Volatility
2.07
Calmar Ratio
3.16
Return/Max Drawdown
Ulcer Index
1.21
Drawdown depth & duration
Martin Ratio
0.12
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
11,935.6
Backtest Period
2025-05-26 to 2026-07-24
1.2 years
Rebalancing
none
Base Currency
EUR
testing | +16.5% CAGR | ETF Backtest